Keywords: |
antibiotic agent; prednisone; clinical trial; review; fluorouracil; hypertension; antineoplastic agents; antineoplastic agent; neoplasms; unindexed drug; thoracotomy; oxygen; cyclophosphamide; melphalan; steroid; digoxin; cytokine; heart failure; shock; cardiotoxicity; mitoxantrone; octreotide; hydrocortisone; anthracycline derivative; echocardiography; cardiomyopathies; trastuzumab; pheochromocytoma; anthracyclines; pericardial effusion; dipeptidyl carboxypeptidase inhibitor; carcinoid tumor; diuretic agent; resuscitation; adrenal gland neoplasms; bone marrow toxicity; cardiomyopathy; heart tamponade; cardiac tamponade; artificial ventilation; serotonin; hypertensive agent; inotropic agent; alpha adrenergic receptor blocking agent; heart diseases; adrenal insufficiency; 5 hydroxyindoleacetic acid; carcinoid syndrome; amyloid; heart transplantation; septic shock; bacterial endocarditis; glyceryl trinitrate; heart tumor; shock, septic; elastase; adrenal gland diseases; free radical; heart failure, congestive; nitroprusside sodium; humans; human; priority journal; digitalis; neopterin; pericardiectomy; pericardiocentesis
|